Stephen Hoffman

Stephen Hoffman

Direktor/Vorstandsmitglied bei RESEARCH ALLIANCE CORP. II

Vermögen: 7 229 $ am 31.05.2026

72 Jahre
Health Technology
Finance
Consumer Services

Profil

Stephen J.
Hoffman
was the founder of Somatogen, Inc., founded in 1987, where the title held was Vice President-Science & Technology from 1987 to 1990.
Current jobs include Chairman at Apic Bio, Inc. since 2021; Independent Director at Research Alliance Corp.
II since 2021; Independent Director at Talphera, Inc. since 2010; Director at Implicit Bioscience Ltd. since 2022; Director at Receptor Life Sciences, Inc. since 2021; and Director at BYOMass, Inc. since 2021.
Former jobs include Chief Executive Officer & Director at Aerpio Therapeutics LLC; Chief Executive Officer & Director at Aerpio Pharmaceuticals, Inc. from 2017 to 2019; Chairman at Bicycle Therapeutics Plc from 2016 to 2019; Chairman at Allos Therapeutics, Inc. from 2002 to 2012; Chairman at Anchiano Therapeutics Ltd. from 2018 to 2019; Director at Danforth Advisors LLC from 2020 to 2021; Director at Sirtris Pharmaceuticals, Inc. from 2004 to 2008; Non-Executive Director at Hovione Farmaciência SA; Managing Director at Skyline Management LLC from 2007 to 2014; Independent Director at Genocea Biosciences, Inc. from 2013 to 2017; Director at Concert Pharmaceuticals, Inc.; Director at KAI Pharmaceuticals, Inc.; Director at Proteon Therapeutics, Inc.; Independent Director at Dicerna Pharmaceuticals, Inc. from 2007 to 2021; Director at Helomics Corp.; Director at Tolerx, Inc.; Director at PPD Dermatology LLC; Director at Sutro Biopharma, Inc.; Director at Palleon Pharmaceuticals, Inc.; Director at Collegium Pharmaceutical, Inc.; Vice President-Science & Technology at Baxter International, Inc. from 1987 to 1990; General Partner at TVM Capital GmbH from 2003 to 2007; and General Partner at TVM Capital Corp.
from 2003 to 2007.
Education includes doctorate degrees from Northwestern University and The University of Colorado School of Medicine.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
24.04.2026 8’859 ( 0.02% ) 7 229 $ 31.05.2026

Aktive Positionen von Stephen Hoffman

UnternehmenPositionBeginn
TALPHERA, INC. Direktor/Vorstandsmitglied 01.02.2010
RESEARCH ALLIANCE CORP. II Direktor/Vorstandsmitglied 01.03.2021
Direktor/Vorstandsmitglied 01.10.2022
Direktor/Vorstandsmitglied 27.10.2021
Direktor/Vorstandsmitglied 18.03.2021
Vorsitzender 05.01.2021

Ehemalige bekannte Positionen von Stephen Hoffman

UnternehmenPositionEnde
DICERNA PHARMACEUTICALS, INC. Direktor/Vorstandsmitglied 28.12.2021
Direktor/Vorstandsmitglied 01.12.2021
Direktor/Vorstandsmitglied 01.11.2020
░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Stephen Hoffman im Detail an

Ausbildung von Stephen Hoffman

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

66

Beziehungen ersten Grades

32

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen32

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Finance

Consumer Services

Health Services

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Technology Services

Commercial Services

Finance

  1. Börse
  2. Insiders
  3. Stephen Hoffman
- 40 %: Die besten Tools - exklusiv für Abonnenten - um schon heute die Top-Anlagechancen von morgen zu erkennen!
T
:
:
PROFITIEREN SIE JETZT